This year’s Single-Cell Sequencing Conference explores that expanding frontier of genomic research. The finer molecular details scientists can now study in individual cells reveal variations that enhance our understanding of tumors and how to predict and treat them. The event includes:
The event will take place August 20-21 in Washington, DC as part of the 2014 Next Generation Dx Summit. For full program details, visit http://www.nextgenerationdx.com/Single-Cell-Sequencing or download the conference brochure.
- Keynote Presentations on Sequencing at the Limits of Detection, with Dr. Sunney Xie of Harvard University and Dr. Maximilian Diehn of Stanford University
- Single-Cell Analysis: From Diagnosis to Therapy, on patient-derived cancer stem cells, intratumor heterogeneity in breast cancer, and even metabolomics and proteomics
- Tips ‘n Tricks for a New Sequencing Frontier, from massively parallel sequencing to CTC analysis methods, across brain tumors, aging and cancer
- Translating into the Clinic, featuring insights into ensuring SCS’s economic viability, regulatory compliance and clinical utility
- Interactive Panel Discussion: From Discovery to Diagnostic, on developing an effective, integrative business model that supports our progress toward personalized medicine
The event will take place August 20-21 in Washington, DC as part of the 2014 Next Generation Dx Summit. For full program details, visit http://www.nextgenerationdx.com/Single-Cell-Sequencing or download the conference brochure.